Evaluation of invitro α-amylase and α-glucosidase inhibitory potential of N2O2 schiff base Zn complex  by Balan, Kannan et al.
Arabian Journal of Chemistry (2015) xxx, xxx–xxxKing Saud University
Arabian Journal of Chemistry
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEEvaluation of invitro a-amylase and a-glucosidase
inhibitory potential of N2O2 schiﬀ base Zn complexAbbreviations: ABTS, 2,20-azinobis-3-ethylbenzothiazoline-6-sulfonic
acid; DNS, dinitro salicylic acid; DPPH, 1-1-diphenyl 2-picryl
hydrazyl; IC50, half maximal inhibitory concentration; LB,
Lineweaver–Burk; MIC, minimum inhibitory concentration; S. aureus,
Staphylococcus aureus; S. typhi, Salmonella typhi; ZnL complex, N2O2
Schiff base Zn complex
* Corresponding author. Tel.: +91 427 2345766/520; fax: +91 427
2345124.
E-mail address: pal2912@yahoo.com (T. Palvannan).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.arabjc.2014.07.002
1878-5352 ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
Please cite this article in press as: Balan, K. et al., Evaluation of invitro a-amylase and a-glucosidase inhibitory potential of N2O2 schiﬀ base Zn complex.
Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.07.002Kannan Balan a, Periyasamy Ratha a, Govindan Prakash b,
Periyasamy Viswanathamurthi b, Sirichai Adisakwattana c,
Thayumanavan Palvannan a,*a Laboratory of Bioprocess and Engineering, Department of Biochemistry, Periyar University, Salem 636 011, Tamil Nadu, India
b Department of Chemistry, Periyar University, Salem 636 011, Tamil Nadu, India
c Department of Nutrition and Dietetics, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, ThailandReceived 18 September 2012; accepted 5 July 2014KEYWORDS
ZnL complex;
Antioxidant;
Antibacterial;
Kinetic studiesAbstract The evaluation of the antioxidant, antibacterial and enzyme inhibition effects of N2O2
Schiff base Zn complex was investigated. The percentage scavenging activity of hydroxyl radical
(IC50-0.21 lg), ABTS (IC50-0.19 lg) and DPPH (IC50-0.25 lg) shows that ZnL complex had a poten-
tial antioxidant activity. The antibacterial activity of ZnL complex was evaluated. Results showed
that MIC value against Staphylococcus aureus and Salmonella typhi was 100 and 200 lg/ml, respec-
tively. ZnL complex showed strong inhibition toward a-amylase and a-glucosidase with an IC50 value
of 0.18 and 0.23 lg, respectively. The inhibition mechanism was analyzed with LB and Dixon plots.
The ZnL complex could be a mixed noncompetitive and noncompetitive inhibitor with Ki values of
77.8 and 31.6 lg for a-amylase and a-glucosidase, respectively. The preliminary assessment of ZnL
complex showed that they can be used as an antioxidant, antibacterial and antidiabetic agents.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Metal complexes play an essential role in agriculture, pharma-
ceutical and industrial chemistry. Ligand, a metal surrounded
by a cluster of ions or molecule, is used for the preparation of
complex compounds named as Schiff bases, which are
condensation products of primary amines and aldehydes or
ketones (RCH=NR0, where R & R0 represent alkyl and/or
aryl substituents) (Dhar and Taploo, 1982). Many Schiff bases
are known to be medicinally important and used to design
medicinal compounds (Khan et al., 2008; Iqbal et al., 2009).
It was seen that the biological activity of Schiff bases either
increases or decreases upon chelation with metal ionsArabian
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Figure 1 Structure of N2O2 Schiff base Zn complex.
2 K. Balan et al.(Kulkarni et al., 2009; Puthilibai et al., 2009; Avaji et al.,
2009). Schiff bases and their metal complexes show antibacter-
ial activities against Escherichia coli, Staphylococcus aureus,
Streptococcus pyogenes, Pseudomonas aeruginosa and
Salmonella typhi and antifungal activities against Aspergillus
niger, Aspergillus ﬂavus and Cladosporium (Bagihalli et al.,
2008). Free radicals, produced as a result of normal biochemi-
cal reactions in the body, are implicated in contributing to
cancer, atherosclerosis, aging, immunosuppression, inﬂamma-
tion, ischemic heart disease, diabetes, hair loss, and neurode-
generative disorders such as Alzheimer’s disease and
Parkinson’s disease (Beal, 1995; Maxwell, 1995; Poulson
et al., 1998).
Diabetes mellitus is a clinical syndrome with severe socioe-
conomic importance characterized by hyperglycemias due to
absolute or relative lack of insulin (Aguwa, 2004). One of
the strategies adopted to treat diabetes mellitus involves inhibi-
tion of carbohydrate-digesting enzymes such as a-amylase and
a-glucosidase in the gastrointestinal tract, with associated
retardation of intestinal glucose absorption and lowering of
postprandial blood glucose levels (Rhabasa-Lhoret and
Chiasson, 2004). a-Glucosidase cleaves glycosidic bonds in
complex carbohydrate to release absorbable monosaccharides.
Inhibitors of a-glucosidase display useful anti-hyperglycemic
effects (Stuart et al., 2004). In the present study determination
of antioxidant and antibacterial activities of ZnL complex and
evaluation of ZnL complex in the inhibition of a-amylase and
a-glucosidase, were carried out. Enzyme kinetic studies were
also performed to understand the possible mode of inhibition
of ZnL complex.2. Materials and methods
2.1. Chemicals
ABTS (2,20-azinobis-3-ethylbenzothiazoline-6-sulfonic acid),
DPPH, p-nitrophenyl-a-D-glucopyranoside, a-amylase and a-
glucosidase were purchased from Sigma–Aldrich Chemical
Corporation, St. Louis, Mo, USA. DNS (dinitro salicylic acid)
was obtained from Himedia chemicals, India, and all other
chemicals were of analytical grade.
2.2. Synthesis and characterization of bis(3-acetyl-5-methyl-
pyran-2,4-dione)ethylenediimine Zn(II) complex complex
(ZnL)
The Schiff base ligand, bis(3-Acetyl-5-methyl-pyran-2,4-
dione)ethylenediimine (H2L) and its Zinc complex (ZnL) were
synthesized according to the procedure of Ponnam deshmukg
et al., 2010 with slight modiﬁcation. H2L was prepared from
the condensation of dehydroacetic acid and ethylene diamine
in ethanol medium at 70 C. The Zn(II) Schiff base complex
(ZnL) was synthesized from the ligand (Fig. 1). Color: Pale
yellow; Yield: 62%; Melting point: 163 C.
In the next step, the ligand (1.1232 g, 4 mmol) was dissolved
in ethanol (20 ml) by heating at 80 C. The obtained solution
was mixed with ethanol containing zinc chloride dehydrate
drop by drop with continuous stirring and the resulting
reaction mixture was further reﬂuxed for 5 h. On cooling the
reaction mixture, a solid product gets settled. The productPlease cite this article in press as: Balan, K. et al., Evaluation of invitro a-amylase a
Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.07.002was ﬁltered, washed with absolute ethanol followed by petro-
leum ether and dried in vacuum. Color: Brown; Yield: 74%;
Melting point: 226 C.
2.3. Antioxidant activity
2.3.1. Determination of hydroxyl radical scavenging activity
The hydroxyl radical scavenging activity of ZnL complex was
determined according to the method of Smirnoff and Cumbes
(1989). Different concentrations of ZnL complex (100–500 lg/
ml), were added to 1 mM FeCl3, 1 mM EDTA, 20 mM H2O2,
1 mM L-ascorbic acid and 30 mM deoxyribose in potassium
phosphate buffer (pH 7.4) and were incubated for 1 h at
37 C. In addition of 1 ml of 2.8% (w/v) trichloroacetic acid
and 1 ml of 1% (w/w) 2-thiobarbituric acid the solution mix-
ture was heated in a boiling water-bath for 15 min and the
absorbance was measured at 532 nm. Ascorbic acid was used
as a positive control.
2.3.2. DPPH (1-1-diphenyl 2-picryl hydrazyl)
The DPPH scavenging activity was determined by an assay
modiﬁed method of Kwon et al. (2006). Solution of DPPH
in ethanol (0.1 mM) was prepared and 1.0 ml of this solution
was added to 2 ml of ZnL complex solution at different
concentrations (100–500 lg/ml) and the reaction mixture was
vortexed for 10 s and allowed to stand at room temperature
for 30 min. The absorbance was recorded at 517 nm by using
a UV–Vis spectrophotometer. The percentage of DPPH radi-
cal scavenging activity was expressed as [1  (Test sample
absorbance/Blank sample absorbance)] · 100 (%). Ascorbic
acid was used as reference antioxidant compound.
2.3.3. ABTS (2,20-azinobis-3-ethylbenzothiazoline-6-sulfonic
acid)
The ABTS radical scavenging assay was carried out according
to the method given by Arnao et al. (2003). The ABTS radical
solution was prepared freshly by adding 5 ml of 4.9 mM
ammonium persulfate solution to 5 ml of a 14 mM ABTS solu-
tion and kept for 16 h under dark condition. The solution was
diluted with distilled water to yield an absorbance of
0.70 ± 0.02 at 734 nm and the same was used for the assay.
Different concentrations of ZnL complex (100–500 lg/ml)
were prepared. A total of 900 ll of ABTS radical solution,
was added to 100 ll of the ZnL complex and the reaction mix-
ture was vortexed for 10 Sec. Absorbance at 734 nm was noted
after six min against the blank by using a UV–Vis spectropho-
tometer. The test solution was compared with the control
ABTS solution and expressed as ABTS+ scavenging activity
in percentage as 1  (Test sample absorbance/Blank samplend a-glucosidase inhibitory potential of N2O2 schiﬀ base Zn complex. Arabian
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compound.
2.4. Antibacterial analysis
Antibacterial activity was performed according to the method
of Threlfall et al. (1999) and Walker et al. (2000) using 10 g
peptone, 10 g NaCl and 5 g yeast, 20 g agar in 1000 ml of dis-
tilled water. The stock cultures of bacteria were revived by
inoculating in broth media and grown at 37 C for 18 h.
Agar plates were prepared and wells were made in the plate.
Each plate was inoculated with 18 h old cultures (100 ll, 104
cfu) and spread evenly on the plate. After 20 min, the wells
were ﬁlled with compound of different concentrations. The
control wells with gentamicin were also prepared. The plates
were incubated at 37 C for 24 h and all the tests were per-
formed in triplicate and the average was taken as ﬁnal reading.
The inhibition zone diameters were measured in millimeters.
2.5. a-Amylase inhibition assay
a-Amylase inhibitory activity was determined by the method
described by the Worthington Enzyme Manual (Worthington
Biochemical Corp., 1993a) with slight modiﬁcation. A total
of 500 ll of ZnL complex and 500 ll of 0.02 M sodium phos-
phate buffer (pH 6.9 with 0.006 MNaCl) containing a-amylase
solution (1.0 U/ml) was incubated at 25 C for 10 min. After
pre incubation, 500 ll of 1% starch solution was added to
0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M
NaCl). The reaction mixture was then incubated at 25 C for
10 min. The reaction was stopped by adding 1.0 ml of DNS
color reagent. The test tubes were then incubated in a boiling
water bath for 5 min and cooled to room temperature. The
reaction mixture was then diluted by adding 10 ml of distilled
water, and absorbance was measured at 540 nm. The a-amy-
lase inhibitory activity was calculated according to the equa-
tion given below:
Inhibition ð%Þ ¼ ðAcontrol  AsampleÞ=Acontrol  100
where Acontrol was the absorbance of the control (without ZnL
complex); Asample was the absorbance in the presence of ZnL
complex.
2.6. a-Glucosidase inhibition assay
A modiﬁed version of the assay described by the Worthington
Enzyme Manual was followed (Worthington Biochemical
Corp., 1993b). A volume of 500 ll of ZnL complex was diluted
with 100 ll of 0.1 M potassium phosphate buffer (pH 6.9) con-
taining a-glucosidase solution (1.0 U/ml) and was incubated in
96-well plates at 25 C for 10 min. After pre incubation, 50 ll
of 5 mM p-nitrophenyl-a-D-glucopyranoside solution in 0.1 M
potassium phosphate buffer (pH 6.9) was added to each well at
timed intervals. The reaction mixtures were incubated at 25 C
for 5 min. The a-glucosidase inhibitory activity was expressed
as percentage of inhibition and was calculated as follows:
Inhibition ð%Þ ¼ ðAcontrol  AsampleÞ=Acontrol  100
where Acontrol was the absorbance of the control (without ZnL
complex); Asample was the absorbance in the presence of ZnL
complex.Please cite this article in press as: Balan, K. et al., Evaluation of invitro a-amylase a
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The mode of inhibition of a-amylase and a-glucosidase by ZnL
complex was determined by using Dixon and Lineweaver–
Burk plots. Starch in the concentration range 0.5–2%, and
p-nitrophenyl-a-D-glucopyranoside in the range 0.5–2 mM,
were used as substrates for a-amylase and a-glucosidase
respectively. The inhibitions of enzyme activities are deter-
mined in the presence and absence of ZnL complex at different
concentrations for a-amylase (50–200 lg/ml) and a-glucosi-
dase (20–80 lg/ml). The values of kinetic parameters (Km
and Ki) were determined according to the type of inhibition
for each enzyme reaction with ZnL complex by both LB and
Dixon plots (Bowden, 1974; Dixon, 1953).
2.8. Statistical analysis
Analysis at every time point from each experiment was carried
out in triplicates. The results were statistically analyzed by
ANOVA. Statistical signiﬁcance was accepted at a level of
p< 0.05.
3. Results and discussion
3.1. Synthesis and characterization
IR spectrum of ligand (H2L) exhibits characteristic peaks at
3282, 2818, 1638, and 1616 cm1 which correspond to phenolic
(–O–H) stretching, C–H stretching, carbonyl (C‚O) stretch-
ing and azomethine (C‚N) stretching vibration frequencies,
respectively. Phenolic (O-H) stretching disappeared in the IR
spectrum of complexes which indicates the binding of ligand
with ‘Zn’ ion via deprotonation. The IR spectrum of ZnL exhi-
bits C‚O stretching at 1633 cm1, almost similar to that of
ligand spectrum. This shows that the carbonyl group remains
free and does not involve in any new bonding. Whereas the
azomethine frequency undergoes a red shift (1607 cm1) in
complexes. This clearly shows the binding of azomethine nitro-
gen with Zn ion. Thus, the IR spectra of H2L and ZnL clearly
exhibit the binding of ligand with metal through two azome-
thine nitrogens and two phenolic oxygens. UV–Vis spectrum
was recorded for the complex ZnL, which exhibits three peaks
at wavelengths (kmax) 224, 286 and 424 nm. Bands at 224 and
286 nm were attributed to intra ligand electronic transitions.
Peaks at 424 nm can be due to M-L charge transfer.
1H-NMR spectra of H2L and ZnL further conﬁrm the
binding of ligand with Zn ion. Phenolic OH proton exhibits
a peak at the chemical shift of 11.4 ppm. This peak disappear
in the 1HNMR spectra of ZnL conﬁrms the deprotonation due
to the binding of phenolic oxygen with the metal group. The
peaks corresponding to free methyl groups have been observed
at similar region (2.1–2.5 ppm) in both the spectrum of ligand
and complex. Methylene (–CH2–) protons and ring (C–H) pro-
tons exhibit their peaks around 2.8 and 3.6 ppm, receptively.
The spectral results conﬁrm that H2L acts as a binegative
quadridentate ligand in nature.
3.2. Hydroxyl radical scavenging activity
In the present study the ZnL complex exhibited a signiﬁcant
strongest hydroxyl radical scavenging activity as comparednd a-glucosidase inhibitory potential of N2O2 schiﬀ base Zn complex. Arabian
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Figure 2 Hydroxyl radical scavenging activity of the ZnL
complex. Mean inhibition (%) ± SDn signiﬁcantly different
(p< 0.05), n= values are given as mean of three replicates.
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Figure 3 The DPPH radical scavenging activity of ZnL complex.
Mean inhibition (%) ± SDn signiﬁcantly different (p< 0.05),
n= values are given as mean of three replicates.
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Figure 4 The ABTS scavenging activity of ZnL complex. Mean
inhibition (%) ± SDn Signiﬁcantly different (p< 0.05), n= val-
ues are given as mean of three replicates.
4 K. Balan et al.with ascorbic acid Fig. 2. IC50 values of ZnL complex and
ascorbic acid were found to be 0.21 and 0.18 lg/ml, respec-
tively (Table 1). This result shows that ZnL complex exhibited
a dose dependent antioxidant activity. The free radicals such as
hydroxyl and superoxide radical are formed in biological sys-
tems and they have been associated as an extremely damaging
species in free radical pathology, capable of injurious to almost
every molecule found in living cells (Gulcin, 2006). Hydroxyl
radicals are very strongly reactive oxygen species and there is
no speciﬁc enzyme to defend against them in humans (Liu
et al., 2005).
3.3. Inhibition of DPPH radical scavenging activity
(1-1-diphenyl 2-picryl hydrazyl)
The highest DPPH scavenging activity was found in ZnL com-
plex. The scavenging activity of ZnL complex was compared
with that of ascorbic acid. The results showed that, ZnL com-
plex had signiﬁcant scavenging effects with increasing concen-
tration in the range of 100–500 lg/ml. When compared to
ascorbic acid; the scavenging effect of ZnL complex was lower.
The IC50 values were found to be 0.25 and 0.22 lg/ml for ZnL
complex and ascorbic acid, respectively (Table 1). DPPH
scavenging activity of the ZnL complex is a dose dependent
in vitro antioxidant activity. The method was based on the
reduction of alcoholic DPPH solution in the presence of a
hydrogen-donating antioxidant due to the formation of the
non-radical DPPH (Soares et al., 1997). Fig. 3 displays the
DPPH activity of ZnL complex in percentage of free radical
scavenging activity. The higher DPPH radical-scavenging
activity is associated with the lower IC50 value. The DPPH
was determined by the decrease in its absorbance at 517 nm.
The DPPH scavenging method has been used to evaluate theTable 1 Effect of ZnL complex half maximal inhibitory
concentration (IC50) on different antioxidant activities.
Types of assay Ascorbic
acid (lg/ml) IC50
N2O2 Schiﬀ base ZnL
complex (lg/ml) IC50
FRAP 0.18 0.21
ABTS 0.1 0.19
DPPH 0.22 0.25
Please cite this article in press as: Balan, K. et al., Evaluation of invitro a-amylase a
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ity, sensitivity and reproducibility (Ozcelik et al., 2003). The
absorbance decreased when the DPPH is scavenged by an
antioxidant through donation of hydrogen to form a stable
DPPH radical molecule. In the radical form, this molecule
has an absorbance at 517 nm, which disappears after accep-
tance of an electron or hydrogen radical from an antioxidant
compound to become a stable diamagnetic molecule
(Matthaus, 2002). When DPPH reacts with suitable reducing
agents, the electrons become paired off and the solutions lose
color stoichiometrically depending upon the incoming electron
(Rock et al., 1996; Sies and Stahl 1995).
3.4. ABTS (2,20-azinobis-3-ethylbenzothiazoline-6-sulfonic
acid) radical scavenging assay
ABTS radical-scavenging is a common method used to assess
the antioxidant activity of the ZnL complex compared to that
of ascorbic acid. In the present study the reduction of ABTS by
ZnL complex was determined and the reducing capacity of
ZnL complex was noted. ZnL complex and ascorbic
acid scavenged the ABTS radicals at a concentration of
100–500 lg/ml. IC50 value of ZnL complex and ascorbic acid
was 0.1 and 0.19 lg/ml, respectively. The result is shown in
Table 1. As shown in Fig. 4, the ZnL complex displayed poten-
tial scavenging effect of ABTS radicals. ABTS radical cationnd a-glucosidase inhibitory potential of N2O2 schiﬀ base Zn complex. Arabian
Table 2 Anti bacterial activity of ZnL complex.
Concentration (lg/ml) Tested strains (mm)
S. aureus S. typhi S. aureus S. typhi
N2O2 Schiﬀ base ZnL complex Gentamicin mm
25 ve ve 13–15 2–4
50 ve ve 18–20 13–15
100 5–8 ve 21–23 16–19
200 10–12 7–10 25–28 21–24
400 16–19 15–17 27–30 25–28
800 24–28 21–24 34–36 27–30
MIC value 100 200 <25 25
MIC (lg/ml)-minimum inhibitory concentration. The zone of inhibition was measured in mm and gentamicin was used as standard drug for
anti-bacterial activity.
0
20
40
60
80
100
100 200 300 400 500
In
hi
bi
tio
n 
of
 α
-
am
yl
as
e
ac
tiv
ity
 (%
)
Concentration ZnL (μg/ml)
Maltose
ZnL complex
Figure 5 Inhibition of a-amylase activities by ZnL complex.
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Figure 6 Inhibition of a-glucosidase activities by ZnL complex.
Table 3 Mode of inhibition and kinetic properties of ZnL
complex on a-amylase and a-glucosidase.
Parameter a-Amylase a-Glucosidase
Km 0.35 1.4
Ki (lg) 77.8 31.6
Mode on inhibition Mixed noncompetitive Noncompetitive
IC50 (mg) 0.18 0.23
Evaluation of invitro a-amylase and a-glucosidase inhibitory potential of N2O2 schiff base Zn complex 5decolorization technique was a widely accepted method/assay
(Greene et al., 1987). ABTS radical is a blue chromophore
produced by the reaction of ABTS and potassium persulfate
after incubation in the dark environment. The reaction of
ZnL complex with this preformed radical cation decolorized
the blue chromophore with increasing concentration
(Igbinosa et al., 2011).
3.5. Antibacterial activity
ZnL complex was screened for their antibacterial activity
against S. aureus and S. typhi. Table 2 shows the antibacterial
activity of ZnL complex. The results showed that ZnL complex
exhibited a potential antibacterial activity against the standard
drug gentamicin (S. aureus and S. typhi), respectively
(Table 2).The ZnL complex exhibited signiﬁcant activity and
the zone of inhibition was up to 24–28 and 21–24 mm at a
concentration of 800 lg/ml against S. aureus and S. typhi
respectively. Schiff base derived from furylglyoxal and
p-toluidene showed antibacterial activity against E. coli, S.
aureus, Bacillus subtilis and Proteus vulgaris. Metal complexes
of Mo(IV) and Mn(II) with ligands hydrazine carboxamide
and hydrazine carbothiamide showed antibacterial activity
against S. aureus and Xanthomonas compestris (Bhardwaj
and Singh 1994). Bharti et al. (2010) reported that 2,4-disubsti-
tuted thiazole ring which was carrying imino-1,2 diphenyletha-
nol substituent appeared to exhibit the highest anti-bacterial
activity against S. aureus and Vibrio cholera with the MIC of
12.5 and 25 lg/ml. The 6,8-dibromo-4(3H) quinazolinone
derivatives were screened for their antibacterial activity against
S. aureus and it exhibited the MIC of 25 lg/ml (Mosaad
Mohamed et al., 2010).
3.6. Inhibition of a-amylase and a-glucosidase activity
The a-amylase and a-glucosidase inhibitory properties of the
ZnL complex are presented in Figs. 5 and 6. The ZnL complex
inhibited both a-amylase and a-glucosidase in a dose depen-
dent manner. The IC50 values for a-amylase and a-glucosidase
were found to be 0.18 and 0.23 mg ZnL complex, respectively
(Table 3). Inhibition of enzymes involved in the hydrolysis of
carbohydrates such as a-amylase and a-glucosidase has been
exploited as a therapeutic approach for controlling postpran-
dial hyperglycemia (Shim et al., 2003). The inhibition activity
of a-amylase was extended and might be responsible forPlease cite this article in press as: Balan, K. et al., Evaluation of invitro a-amylase a
Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.07.002decreasing the rate of glucose absorption and concentration
of postprandial serum glucose (Chau et al., 2003; Kwon
et al., 2007). This effect would delay the degradation of starch
and oligosaccharides, which would in turn cause a decrease in
the absorption of glucose and consequently inhibit the increasend a-glucosidase inhibitory potential of N2O2 schiﬀ base Zn complex. Arabian
Figure 7 LB plot analysis of the inhibition kinetics of (A) a-amylase and (B) a-glucosidase effects by ZnL complex.
Figure 8 Dixon plot analysis of kinetic constants of (A) a-amylase and (B) a-glucosidase effects by ZnL complex.
6 K. Balan et al.in postprandial blood glucose (Lee et al., 2007). In the human
species, a-amylase is present in both salivary and pancreatic
secretions. This enzyme is responsible for cleaving large
malto-oligosaccharides to maltose, which is then a substrate
for intestinal a-glucosidase (Ramasubbu et al., 2004).
3.7. Mode of inhibition
ZnL complex is likely to inﬂuence the a-amylase and a-glucosi-
dase in quite a number of ways, for instance it competes with
the substrate to bind the active site of the enzyme or it disrupts
the catalytic process irreversibly. Kinetic studies were carried
out to identify the mode of inhibition of ZnL complex using
the LB plot. Fig. 7A and B shows the straight lines intercepting
at a single point in the second quadrant indicating mixed non-
competitive and noncompetitive inhibition for a-amylase and
a-glucosidase with inhibitory constant (Ki) value of ZnL
complex of 77.8 and 31.6 lg, respectively (Fig. 8A and B).
Kinetic constants (Ki) for the inhibition of a-glucosidase and
a-amylase are listed in Table 3. Apostolidis et al. (2007)
reported that kinetic inhibition of porcine pancreatic
a-amylase by acarbose, maltose and maltotriose was mixed
non-competitive type inhibition.
4. Conclusion
In the present investigation, ZnL complex showed good
antioxidant activity. Antibacterial activity of ZnL complexPlease cite this article in press as: Balan, K. et al., Evaluation of invitro a-amylase a
Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.07.002was evaluated against microorganisms S. aureus and S. typhi.
Antibacterial activity of ZnL complex was noticed to be higher
in case of S. aureus than in S. typhi. In vitro studies displayed
that the complex showed a potential inhibitory activity of a-
amylase and a-glucosidase. The in vitro analysis provides an
insight of enzyme inhibitory activity of ZnL complex. The
ZnL complex is found to be an effective mixed non competitive
and non competitive inhibitor of a-amylase and a-glucosidase
respectively. These ﬁndings provided scientiﬁc evidence to
support ZnL complex as a potential candidate to be used as
an antioxidant, antibacterial and antidiabetic drugs.References
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